| __timestamp | MannKind Corporation | Novo Nordisk A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 79383000 | 26760000000 |
| Thursday, January 1, 2015 | 108402000 | 32169000000 |
| Friday, January 1, 2016 | 46928000 | 32339000000 |
| Sunday, January 1, 2017 | 74959000 | 32124000000 |
| Monday, January 1, 2018 | 79716000 | 33313000000 |
| Tuesday, January 1, 2019 | 74669000 | 35830000000 |
| Wednesday, January 1, 2020 | 59040000 | 36886000000 |
| Friday, January 1, 2021 | 77417000 | 41058000000 |
| Saturday, January 1, 2022 | 91473000 | 50684000000 |
| Sunday, January 1, 2023 | 94314000 | 61598000000 |
| Monday, January 1, 2024 | 67377000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Novo Nordisk A/S and MannKind Corporation, two giants in the industry, have shown contrasting approaches over the past decade. From 2014 to 2023, Novo Nordisk's SG&A expenses have consistently been higher, peaking at approximately $61.6 billion in 2023. This represents a staggering 130% increase from 2014. In contrast, MannKind Corporation's expenses have been more modest, with a peak of around $94 million in 2023, marking a 19% increase from 2014.
While Novo Nordisk's larger scale justifies its higher expenses, MannKind's leaner approach highlights its focus on cost efficiency. This comparison underscores the diverse strategies companies employ to optimize operational costs, reflecting their unique market positions and growth trajectories.
Novo Nordisk A/S or Vertex Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or Ultragenyx Pharmaceutical Inc.
Comparing SG&A Expenses: Novo Nordisk A/S vs ImmunityBio, Inc. Trends and Insights
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or MorphoSys AG
SG&A Efficiency Analysis: Comparing Novo Nordisk A/S and HUTCHMED (China) Limited
SG&A Efficiency Analysis: Comparing Viatris Inc. and MannKind Corporation
Dr. Reddy's Laboratories Limited and MannKind Corporation: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Halozyme Therapeutics, Inc. or MannKind Corporation
Breaking Down SG&A Expenses: Amicus Therapeutics, Inc. vs MannKind Corporation
Breaking Down SG&A Expenses: MannKind Corporation vs Travere Therapeutics, Inc.
MannKind Corporation and Novavax, Inc.: SG&A Spending Patterns Compared